1.Clinical and angiographic correlates of left ventricular dysfunction in patients with three vessel coronary disease.
Zhan GAO ; Bo XU ; Yue-Jin YANG ; David E KANDZARI ; Jin-Qing YUAN ; Jue CHEN ; Ji-Lin CHEN ; Shu-Bin QIAO ; Yong-Jian WU ; Hong-Bin YAN ; Xue-Wen QIN ; Min YAO ; Hai-Bo LIU ; Jun DAI ; Tao CHEN ; Si-Yong TENG ; Run-Lin GAO
Chinese Medical Journal 2012;125(23):4221-4225
BACKGROUNDAmong patients with advanced multivessel coronary disease, left ventricular (LV) function is widely variable, and clinical and angiographic correlates of ventricular dysfunction remain to be defined.
METHODSAmong 73 339 patients undergoing diagnostic cardiac catheterization at a single center in China, patients with left ventriculographic assessment were identified with three-vessel coronary disease with or without left main involvement. Clinical and angiographic characteristics were examined among patients with normal or varying extent of LV dysfunction, and predictors of LV impairment (ejection fraction (EF): < 25%, 25% - 40% or > 40%) were determined.
RESULTSAmong 11 950 patients identified with three-vessel coronary disease, the sample distribution of LVEF was > 40%, n = 10 776; 25% - 40%, n = 948; < 25%, n = 226. Patients with reduced LV function (< 40%) more commonly were male and had a history of myocardial infarction (MI), diabetes or unstable angina. Hypertension was more frequent in those with LVEF ≥ 40%. In a multivariate Logistic regression analysis, prior MI (odds ratio (OR), 3.37; 95% confidence interval (CI), 2.96 - 3.84) was most predictive of LVEF < 40%, followed by male gender, diabetes, and presentation with unstable angina. For LVEF < 25%, only prior MI was identified as a significant correlate of severe LV dysfunction (OR 4.06, 95%CI 3.06 - 5.39). Following exclusion of patients with previous MI (n = 7416), male gender and diabetes were predictive of LVEF < 40%, yet presentation with unstable angina was the only factor significantly associated with LVEF < 25%.
CONCLUSIONAmong individuals identified with three-vessel coronary disease with or without left main involvement, previous MI was the most significant risk factor of LV dysfunction.
Aged ; Coronary Angiography ; Coronary Disease ; pathology ; physiopathology ; Female ; Humans ; Male ; Middle Aged ; Ventricular Dysfunction, Left ; pathology ; physiopathology
3.Clinical study of the ascending aorta wall motion by velocity vector imaging in patients with primary hypertension.
Lei, WANG ; Jing, WANG ; Mingxing, XIE ; Xinfang, WANG ; Qing, LV ; Ming, CHEN ; Shaoping, ZHENG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2009;29(1):127-30
We studied the wall motion characteristics of the ascending aorta by velocity vector imaging (VVI) in primary hypertension patients. The ascending aortas both in 30 patients with primary hypertension and 30 normal controls were examined by Acuson sequoia 512 equiped with VVI. The maximum velocity (Vs, Ve) of every point on the anterior wall of ascending aorta both in systole and diastole was measured. The aortic diameter was wider in the hypertension patients than that in the healthy subjects (P<0.05). The movement amplitude of the anterior wall of the ascending aorta in long axis view in the hypertension patients was lower than that in the healthy subjects (P<0.05). The motion and time to peak in systole of each point of the ascending aorta in the healthy subjects had no significant difference (P>0.05). The velocity curves of the anterior wall of ascending aorta both in the hypertension and healthy subjects were regular, and the curve in systole was named S wave and that in diastole named E wave. The velocity of S wave and E wave was slower in the hypertension patients than that in the healthy subjects (P<0.05). The time to peak of S wave on the anterior wall of ascending aorta in systole was shorter in the hypertension patients than in the healthy subjects (P<0.05). VVI could be used to accurately and directly observe the movement character of the ascending aorta walls, which would help us understand the elasticity of great arteries in patients with hypertension.
Aorta/pathology
;
Aorta/*physiopathology
;
Aorta/ultrasonography
;
Blood Flow Velocity
;
Case-Control Studies
;
Echocardiography/*methods
;
Elasticity
;
Hypertension/pathology
;
Hypertension/*physiopathology
;
Vectorcardiography/*methods
;
Ventricular Dysfunction, Left/physiopathology
;
Young Adult
4.Decreased Left Ventricular Torsion and Untwisting in Children with Dilated Cardiomyopathy.
Seon Mi JIN ; Chung Il NOH ; Eun Jung BAE ; Jung Yun CHOI ; Yong Soo YUN
Journal of Korean Medical Science 2007;22(4):633-640
The purpose of this study was to analyze left ventricular (LV) torsion and untwisting, and to evaluate the correlation between torsion and other components of LV contraction in children with dilated cardiomyopathy (DCM). Segmental and global rotation, rotational rate (Vrot) were measured at three levels of LV using the twodimensional (2D) speckle tracking imaging (STI) method in 10 DCM patients (range 0.6-15 yr, median 6.5 yr, 3 females) and 17 age- and sex-matched normal controls. Global torsion was decreased in DCM (peak global torsion; 10.9+/-4.6degrees vs. 0.3+/-2.1degrees, p<0.001). Loss of LV torsion occurred mainly by the diminution of counterclockwise apical rotation and was augmented by somewhat less reduction in clockwise basal rotation. In DCM, the normal counterclockwise apical rotation was not observed, and the apical rotation about the central axis was clockwise or slightly counterclockwise (peak apical rotation; 5.9+/-4.1degrees vs. -0.9+/-3.1degrees, p<0.001). Systolic counterclockwise Vrot and early diastolic clockwise Vrot at the apical level were decreased or abolished. In DCM, decreased systolic torsion and loss of early diastolic recoil contribute to LV systolic and diastolic dysfunction. The STI method may facilitate the serial evaluation of the LV torsional behavior in clinical settings and give new biomechanical concepts for better management of patients with DCM.
Adolescent
;
Cardiomyopathy, Dilated/pathology/*physiopathology
;
Child
;
Child, Preschool
;
Echocardiography, Doppler/methods
;
Female
;
Humans
;
Infant
;
Male
;
Reproducibility of Results
;
Ventricular Dysfunction, Left/pathology/*physiopathology
6.Left Ventricular Filling Pressure as Assessed by the E/e' Ratio Is a Determinant of Atrial Fibrillation Recurrence after Cardioversion.
Hyemoon CHUNG ; Byoung Kwon LEE ; Pil Ki MIN ; Eui Young CHOI ; Young Won YOON ; Bum Kee HONG ; Se Joong RIM ; Hyuck Moon KWON ; Jong Youn KIM
Yonsei Medical Journal 2016;57(1):64-71
PURPOSE: Left ventricular (LV) filling pressure affects atrial fibrillation (AF) recurrence. We investigated the relationship between diastolic dysfunction and AF recurrence after cardioversion, and whether LV filling pressure was predictive of AF recurrence. MATERIALS AND METHODS: Sixty-six patients (mean 58+/-12 years) with newly diagnosed persistent AF were retrospectively enrolled. We excluded patients with left atrial (LA) diameters larger than 50 mm, thereby isolating the effect of LV filling pressure. We evaluated the differences between the patients with (group 1) and without AF recurrence (group 2). RESULTS: Group 1 showed increased LA volume index (LAVI) and E/e' compared to group 2 (p<0.05). During a mean follow-up period of 25+/-19 months, AF recurrence after cardioversion was 60.6% (40/66). The area under the receiver operating characteristics curve of E/e' for AF recurrence was 0.780 [95% confidence interval (CI): 0.657-0.903], and the optimal cut-off value of the E/e' was 9.15 with 75.0% of sensitivity and 73.1% of specificity. A Kaplan-Meier survival curve showed that the cumulative recurrence-free survival rate was significantly lower in patients with higher LV filling pressure (E/e'>9.15) compared with patients with lower LV filling pressure (E/e'< or =9.15) (log rank p=0.008). Cox regression analysis revealed that E/e' [hazards ratio (HR): 1.100, 95% CI: 1.017-1.190] and LAVI (HR: 1.042, 95% CI: 1.002-1.084) were independent predictors for AF recurrence after cardioversion. CONCLUSION: LV filling pressure predicts the risk of AF recurrence in persistent AF patients after cardioversion.
Aged
;
Atrial Fibrillation/*physiopathology
;
Electric Countershock
;
Female
;
Follow-Up Studies
;
Heart Atria/pathology/physiopathology
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Proportional Hazards Models
;
ROC Curve
;
Recurrence
;
Regression Analysis
;
Retrospective Studies
;
Sensitivity and Specificity
;
Survival Rate
;
Ventricular Dysfunction, Left/*physiopathology
7.Immunization with beta(1)-adrenoreceptor peptide induces cardiomyopathy-like changes in rabbit hearts.
Xiaojin HAO ; Sijin LI ; Huirong LIU ; Bowei WU
Chinese Medical Journal 2002;115(2):170-174
OBJECTIVETo investigate the importance of autoimmunity against beta(1)-adrenoreceptor in the pathogenesis of dilated cardiomyopathy (DCM).
METHODSFourteen rabbits were divided equally into two groups. Rabbits in the immunized group (n = 7) were immunized monthly for one year with synthetic peptide corresponding to the second extracellular loop of the beta(1)-adrenoreceptor and adjuvant. Control rabbits received the mixture with the same procedure as described except with a substitution of saline for the corresponding peptide. During the study period, all rabbits were bled to assay the titers of antipeptide antibody and left ventricular ejection fractions (LVEFs) were measured by emission computed tomography. At the end of experiment, invasive cardiac function was measured and morphologic examinations were done.
RESULTSHigh titers of antipeptide antibody were found in the sera from immunized rabbits throughout the study period in contrast to those from control rabbits. LVEFs were significantly higher in immunized rabbits than those of the control group at the 4th and 6th month. At the end of the experiment, the maximal rates of rise and decline of ventricular pressure of the immunized group were significantly lower than those of the control group. Morphological changes were found in immunized rabbits such as the enlargement of ventricles, myofibrillar lysis and necrosis, mitochondria swelling and condensation. No obvious alterations were noted in hearts of control rabbits.
CONCLUSIONAutoimmunity against the beta(1)-adrenoreceptor may be involved in the pathogenesis of dilated cardiomyopathy and beta(1)-adrenoreceptor antibody may play a role in the process.
Animals ; Cardiomyopathy, Dilated ; etiology ; immunology ; pathology ; Heart ; drug effects ; physiopathology ; Immunization ; Male ; Microscopy, Electron ; Myocardium ; pathology ; ultrastructure ; Peptide Fragments ; administration & dosage ; chemical synthesis ; immunology ; Rabbits ; Receptors, Adrenergic, beta-1 ; administration & dosage ; chemistry ; immunology ; Ventricular Dysfunction, Left ; etiology ; physiopathology
8.Catecholamines May Play an Important Role in the Pathogenesis of Transient Mid- and Basal Ventricular Ballooning Syndrome.
Eun Mi KIM ; Jae Hyeong PARK ; Yun Seon PARK ; Jae Hwan LEE ; Si Wan CHOI ; Jin Ok JEONG ; In Whan SEONG
Journal of Korean Medical Science 2008;23(5):898-902
The exact pathogenesis of transient mid- and basal ventricular ballooning, a new variant of transient left ventricular (LV) ballooning, remains unknown. We report two cases of transient mid- and basal ventricular ballooning associated with catecholamines. These cases suggest that catecholamine-mediated myocardial dysfunction might be a potential mechanism of this syndrome.
Adult
;
Cardiomyopathies/pathology
;
Catecholamines/*metabolism
;
Coronary Vessels/pathology
;
Heart Catheterization
;
Heart Ventricles/pathology
;
Humans
;
Male
;
Middle Aged
;
Myocardial Contraction
;
Myocardium/pathology
;
Syndrome
;
Tomography, X-Ray Computed/methods
;
Ventricular Dysfunction, Left/diagnosis/*physiopathology
9.Repair of left ventricular aneurysm: ten-year experience in Chinese patients.
Hong-guang FAN ; Zhe ZHENG ; Wei FENG ; Xin YUAN ; Wei WANG ; Sheng-shou HU
Chinese Medical Journal 2009;122(17):1963-1968
BACKGROUNDA large transmural myocardial infarction often results in a dyskinetic or akinetic left ventricular aneurysm (LVA). This study aimed to explore the early and long-term clinical outcomes and to identify predictors for survivals and hospital re-admission after the repair of left ventricular aneurysm.
METHODSWe followed up 497 patients who had undergone LVA repair from a single center in China between 1995 and 2005. The perioperative parameters were recorded. Risk factors for early mortality and long-term results were analyzed by multivariate Logistic regression. Cox's proportional hazard model was used to calculate risk factors for major adverse cardiac and cerebrovascular events, cause of death and re-admission. Kaplan-Meier curve was employed to analyze long-term survival.
RESULTSThe operative mortality was 2.0%. The long-term mortality was 11.1% and cardiac causes contributed to 61.8% of the overall long-term mortality. Four hundred and thirty-two patients survived during the follow-up period and 37.5% of them had been re-admitted at least one time. One hundred and five patients experienced major adverse cardiac and cerebrovascular events. Survival analysis exhibited that the probability of survival at 1 and 5 years after operation was 96% and 86% respectively. Previous atrial fibrillation was the independent risk factor for early mortality. Independent risk factors for long-term mortality were poor left ventricular ejection fraction and stroke,and risk factors for cardiac mortality were intraventricular block, stroke and poor left ventricular ejection fraction. Stroke, intraventricular block and advanced age were independent risk factors for major adverse cardiac and cerebrovascular events, and New York Heart Association (NYHA) class III-IV was the only risk factor for hospital re-admission.
CONCLUSIONSPostinfarction LVA can be repaired and satisfying early and long-term clinical outcome can be obtained. Endoventricular circular plasty technique is the better choice than linear repair in patients with large LVA. Survival is affected in patients with poor heart function, intraventricular block and stroke.
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Heart Aneurysm ; mortality ; pathology ; surgery ; Humans ; Logistic Models ; Male ; Middle Aged ; Myocardial Infarction ; mortality ; physiopathology ; surgery ; Proportional Hazards Models ; Survival Analysis ; Treatment Outcome ; Ventricular Dysfunction, Left ; pathology ; surgery
10.Sheng-Mai-San attenuates contractile dysfunction and structural damage induced by chronic intermittent hypoxia in mice.
Wei-Lan MO ; Cheng-Zhi CHAI ; Jun-Ping KOU ; Yong-Qing YAN ; Bo-Yang YU
Chinese Journal of Natural Medicines (English Ed.) 2015;13(10):743-750
Sheng-Mai-San (SMS), a well-known Chinese medicinal plant formula, is widely used for the treatment of cardiac diseases characterized by deficiency of Qi and Yin syndrome. A mouse chronic intermittent hypoxia (CIH) model was established to mimic the primary clinical features of deficiency of Qi and Yin syndrome. Mice experienced CIH for 28 days (nadir 7% to peak 8% oxygen, 20 min per day), resulting in left ventricle (LV) dysfunction and structure abnormalities. After administration of SMS (0.55, 1.1, and 5.5 g·kg(-1)·d(-1)) for four weeks, improved cardiac function was observed, as indicated by the increase in the ejection fraction from the LV on echocardiography. SMS also preserved the structural integrity of the LV against eccentric hypotrophy, tissue vacuolization, and mitochondrial injury as measured by histology, electron microscopy, and ultrasound assessments. Mechanistically, the antioxidant effects of SMS were demonstrated; SMS was able to suppress mitochondrial apoptosis as indicated by the reduction of several pro-apoptotic factors (Bax, cytochrome c, and cleaved caspase-3) and up-regulation of the anti-apoptosis factor Bcl-2. In conclusion, these results demonstrate that SMS treatment can protect the structure and function of the LV and that the protective effects of this formula are associated with the regulation of the mitochondrial apoptosis pathway.
Animals
;
Antioxidants
;
pharmacology
;
therapeutic use
;
Apoptosis
;
Cardiomyopathies
;
drug therapy
;
etiology
;
Caspase 3
;
metabolism
;
Cytochromes c
;
metabolism
;
Disease Models, Animal
;
Drug Combinations
;
Drugs, Chinese Herbal
;
pharmacology
;
therapeutic use
;
Heart Ventricles
;
drug effects
;
pathology
;
physiopathology
;
Hypoxia
;
Male
;
Mice, Inbred ICR
;
Mitochondria
;
drug effects
;
metabolism
;
Myocardium
;
pathology
;
Oxygen
;
metabolism
;
Phytotherapy
;
Qi
;
Up-Regulation
;
Ventricular Dysfunction, Left
;
drug therapy
;
etiology
;
bcl-2-Associated X Protein
;
metabolism